Jieer Ying, Qi Xu, Jingjing Li, Qing Wei, Lei Zhang, Shurui Zhou, Meifang Zheng, Yunben Yang. "First-line serplulimab and bevacizumab combined with nab-paclitaxel/gemcitabine followed by mFOLFOX in advanced pancreatic cancer: A phase II trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4162